Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC26A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR3656 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCTD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TACC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIPF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF157 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJB14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HELQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAOK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPHD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMK1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DICER1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on